Incendia Therapeutics
PrivateLast Round
Convertible Debt
Apr 18, 2024
Total Funding Raised
$67.31M
Company Overview
Incendia Therapeutics is a biotechnology company that develops innovative anti-cancer therapies designed to reprogram the tumor microenvironment to enhance treatment efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Incendia Therapeutics Comparables
Compare Incendia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alixia | 87% | |
| ImmunoGenesis | 83% | |
| Sonata Therapeutics | 83% | |
Incendia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Apr 18, 2024 | ||||
| Series A | Nov 3, 2021 |
Key People
Founding team and executive leadership
Incendia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| Creacion Ventures | Series A |
| abrdn Inc. | Convertible Debt |
| Taiho Ventures | Series A |
| Northpond Ventures | Series A |
| Tekla Capital Management | Series A |
| Breakout Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2021
$65M round led by Pfizer Ventures and Taiho Ventures.
Incendia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Incendia Therapeutics's valuation, stock price, and market status.